TNFSF11 and myocardial ischemia: In a highly manipulated murine model of myocardial ischemia (that did not include reperfusion), only selective inhibition of RANKL derived from hematopoietic cellular sources, but not selective inhibition of RANKL from mesenchymal cells, improved post-infarct survival and cardiac function.